Medicared For All Logo

Hafsa Siddiqui in Huntsville, Alabama

Home Alabama Huntsville

Hafsa Siddiqui has Infectious Disease as her primary medical specialty. Their primary office is: 420 Lowell Sedr in Huntsville, Alabama.

They're a part of the: Alabama Infectious Disease Center P.c. medical group which has around 4 members. You can call their office at 256-265-7955 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1999 (around 25 years of experience). They are listed as doing telehealth appointments.


Hafsa H Siddiqui Office Phone and Directions

Hafsa Siddiqui
Alabama Infectious Disease Center P.c.
420 Lowell Sedr
Huntsville, Alabama 35801
256-265-7955


Patient Ratings
Please rate your experience with Hafsa Siddiqui below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 256-265-7955


Enter a starting address:


Healthcare Info for Hafsa Siddiqui

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Hafsa Siddiqui is listed as: Infectious Disease
Approximate Years of Experience: 25
PAC (PECOS ID)#: 8426128570
NPI #: 1447446935
NPI Created On: 09/19/2007
NPI Last Updated Listed as: 01/21/2010
Primary Taxonomy Code: 207RI0200X
License Number:
5836739-1205
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Urdu, English.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 45 minutes
  2. Established patient office or other outpatient visit, typically 15 minutes
  3. Established patient office or other outpatient, visit typically 25 minutes
  4. Initial hospital inpatient care, typically 50 minutes per day
  5. Initial hospital inpatient care, typically 70 minutes per day
  6. Subsequent hospital inpatient care, typically 15 minutes per day
  7. Subsequent hospital inpatient care, typically 25 minutes per day
  8. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796038473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Drug or Biological: Drug

Product Category #2: ANTI-INFECTIVE

Name Of Drug #2:: TEFLARO

Associated Drug #2: 0456-0600-10


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796038475

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Drug or Biological: Drug

Product Category #2: ANTI-INFECTIVE

Name Of Drug #2:: TEFLARO

Associated Drug #2: 0456-0600-10


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796038477

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Drug or Biological: Drug

Product Category #2: ANTI-INFECTIVE

Name Of Drug #2:: TEFLARO

Associated Drug #2: 0456-0600-10


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796038479

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Drug or Biological: Drug

Product Category #2: ANTI-INFECTIVE

Name Of Drug #2:: TEFLARO

Associated Drug #2: 0456-0600-10


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796038481

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Drug or Biological: Drug

Product Category #2: ANTI-INFECTIVE

Name Of Drug #2:: TEFLARO

Associated Drug #2: 0456-0600-10


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 806843365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: TETRACYCLINE CLASS ANTIBACTERIAL

Name of Drug #1: XERAVA

Open Associated Drug #1: 71773-050-12


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 806843369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: TETRACYCLINE CLASS ANTIBACTERIAL

Name of Drug #1: XERAVA

Open Associated Drug #1: 71773-050-12


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834893745

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: EGRIFTA

Open Associated Drug #1: 62064-011-60

Drug or Biological: Drug

Product Category #2: HIV

Name Of Drug #2:: TROGARZO

Associated Drug #2: 62064-122-02


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834893749

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: TROGARZO

Open Associated Drug #1: 62064-122-02

Drug or Biological: Drug

Product Category #2: HIV

Name Of Drug #2:: EGRIFTA

Associated Drug #2: 62064-011-60


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834893753

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HIV

Name of Drug #1: TROGARZO

Open Associated Drug #1: 62064-122-02

Drug or Biological: Drug

Product Category #2: HIV

Name Of Drug #2:: EGRIFTA

Associated Drug #2: 62064-011-60


Infectious Disease Professionals in Huntsville

301 Governors Dr Sw
Huntsville, AL
The Valley Foundation

1102 Monroe St Sw
Huntsville, AL
Metro Infectious Disease Consultants Llc

250 Chateau Dr Sw
Huntsville, AL

250 Chateau Swdr
Huntsville, AL
Scott D Parker Md Llc

4810 Whitesport Circle
Huntsville, AL
Scott D Parker Md Llc

1102 Monroe St Sw
Huntsville, AL
Metro Infectious Disease Consultants Llc

Providers in Alabama Infectious Disease Center P.c.

1.Zohra Chaudhry

420 Lowell Sedr
Huntsville Al 35801-3762
Alabama Infectious Disease Center P.c.
Infectious Disease

2.Ali Hassoun Md

420 Lowell Sedr
Huntsville Al 35801-3762
Alabama Infectious Disease Center P.c.
Infectious Disease

3.Sharad Malavade

420 Lowell Sedr
Huntsville Al 35801-3762
Alabama Infectious Disease Center P.c.
Infectious Disease

4.Hafsa Siddiqui

420 Lowell Sedr
Huntsville Al 35801-3762
Alabama Infectious Disease Center P.c.
Infectious Disease

View all 4 members of Alabama Infectious Disease Center P.c. medical group